Interferon-γ and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action

Cancer Letters

Volumn 121, Issue 2, 1997, Pages 181-188

  Wada, Randal K ^a   Pai, David S M ^a   Huang, Jerry ^a   Yamashiro, Joyce M ^a   Sidell, Neil ^b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interferon ; N myc; Neuroblastoma; Retinoic acid

Indexed keywords

ACTIN; GAMMA INTERFERON; MESSENGER RNA; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO DEVELOPMENT; GENE DELETION; GENE EXPRESSION REGULATION; HALF LIFE TIME; HUMAN; HUMAN CELL; METASTASIS; NEURAL CREST; NEUROBLAST; NEUROBLASTOMA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HALF-LIFE; HUMANS; INTERFERON TYPE II; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031455754     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00351-0     Document Type: Article

References (47)

1. Schwab M., Alitalo K., Klempnauer K.H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G.M., Goldstein M., Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and neuroblastoma tumor. Nature. 305:1983;245-248.
2. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., Bishop J.M. Amplification of N-myc sequences in untreated neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124.
3. Seeger R.C., Brodeur G.M., Sather H., Dalton A., Siegel S.E., Wong K.Y., Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313:1985;1111-1116.
4. Schwab M. Enhanced expression of the cellular oncogene MYCN and progression of human neuroblastoma. Adv. Enzyme Regul. 31:1991;329-338.
5. Hiyama E., Hiyama K., Yokoyama T., Ishii T. Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients. J. Pediatr. Surg. 26:1991;838-843.
6. Bonilla M.A., Cheung N.K.V. Clinical prognosis in neuroblastoma. Cancer Invest. 12:1994;644-653.
7. Everson T.C. Spontaneous regression of cancer. Ann. N. Y. Acad. Sci. 114:1964;721-735.
8. McWilliams N.B. IVS neuroblastoma: treatment controversy revisited. Med. Pediatr. Oncol. 14:1986;41-44.
9. Seeger R.C., Wada R., Brodeur G.M., Moss T.J., Bjork R.L., Sousa L., Slamon D.J. Expression of N-myc by neuroblastoma with one or multiple copies of the oncogene. Prog. Clin. Biol. Res. 271:1988;41-49.
10. Sidell N. Retinoic acid induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J. Natl. Cancer Inst. 68:1982;589-596.
11. Sidell N., Altman A., Haussler M.R., Seeger R.C. Effects of retinoic acid on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp. Cell Res. 155:1983;305-309.
12. Watanabe H., Chisaka T., Higuchi T., Tanaka A., Horii Y., Sugimoto T., Imanishi J. Effect of human interferons on morphological differentiation and suppression of N-myc gene expression in human neuroblastoma cells. Jpn. J. Cancer Res. 80:1989;1072-1076.
13. Parodi M.T., Cornaglia-Ferraris P., Ponzoni M. Effects of γ-interferon on growth, morphology and membrane and cytoskeletal protein expression of LA-N-1 cells. Exp. Cell Res. 185:1989;327-341.
14. Higuchi T., Tanaka A., Watanabe H., Chisaka T., Imanishi J. Rapid phosphorylation of cellular proteins during differentiation of neuroblastoma cells induced by recombinant human interferon-γ J. Interferon Res. 10:1990;413-423.
15. Wuarin L., Verity M.A., Sidell N. Effects of interferon gamma and its interaction with retinoic acid on human neuroblastoma differentiation. Int. J. Cancer. 48:1991;136-141.
16. Rupniak H.T., Rein G., Powell J.P., Ryder T.A., Carson S., Povey S., Hill B.T. Characteristics of a new human neuroblastoma cell line which differentiates in response to cyclic-adenosine 3′-5′-monophosphate. Cancer Res. 44:1984;2600-2607.
17. Pahlman S., Oderstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes in neuroblastoma cells induced by 12-O-tetradecanoyl-phorbol-12-acetate. Int. J. Cancer. 28:1981;583-589.
18. Cinatl J., Cinatl J., Mainke M., Weibflog A., Rabenau H., Kornhuber B., Doerr H.W. In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate. Cancer Lett. 70:1993;15-24.
19. Sidell N., Wada R.K., Han G., Chang B., Shack S., Moore T., Samid D. Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. Int. J. Cancer. 60:1995;507-514.
20. Reynolds C.P., Kane D.J., Einhorn P.A., Matthay K.K., Crouse V.L., Wilbur J.R., Shurin S.B., Seeger R.C. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog. Clin. Biol. Res. 366:1990;203-212.
21. Thiele C.J., Reynolds C.P., Israel M.A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 313:1985;404-406.
22. Thiele C.J., Deutsch L.A., Israel M.A. Multiple proto-oncogenes are differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines. Oncogene. 3:1988;281-288.
23. Thiele C.J., Israel M.A. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Exp. Cell Biol. 56:1988;321-333.
24. Wada R.K., Seeger R.C., Reynolds C.P., Alloggiamento T., Yamashiro J.M., Ruland C., Balck A.C., Rosenblatt J.D. Cell type specificity and retinoic acid response of the human N-myc promoter in neuroblastoma cells. Oncogene. 7:1992;711-717.
25. Wada R.K., Seeger R.C., Brodeur G.M., Einhorn P.A., Rayner S.A., Tomayko M.M., Reynolds C.P. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer. 72:1993;3346-3354.
26. Negroni A., Scarpa S., Romeo A., Ferrari S., Modesti A., Raschella G. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Diff. 2:1991;511-518.
27. Finklestein J.Z., Krailo M.D., Lenarsky C., Ladisch S., Blair G.K., Reynolds C.P., Sitarz A.L., Hammond G.D. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report of the Childrens' Cancer Study Group. Med. Pediatr. Oncol. 20:1992;3073-3081.
28. Cornaglia-Ferraris P., Mariottini G.L., Ponzoni M. γ-Interferon and retinoic acid synergize in inhibiting the growth of human neuroblastoma cells in nude mice. Cancer Lett. 61:1991;215-220.
29. Chirgwin J.M., Przybyia A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18:1979;5294-5299.
30. Ponte P., Gunning P., Blau H., Kedes L. Human actin genes are single copy from alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol. Cell. Biol. 3:1983;1783-1791.
31. Dani C., Blanchard J.M., Piechaczyk M., El Sabouty S., Marty L., Jeanteur P. Extreme instability of myc mRNA in normal and transformed cells. Proc. Natl. Acad. Sci. USA. 81:1984;7046-7050.
32. W.F. Marzluff, R.C.C. Huang, in: B.D. Hames, S.J. Higgins (Eds.), Transcription and Translation: A Practical Approach, IRL, Oxford, 1985, pp. 89-129.
33. Woodruff K.A., Rosenblatt J.D., Moore T.B., Medzoyan R.H., Pai D.S.M., Noland J.L., Yamashiro J.M., Wada R.K. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene. 10:1995;1335-1341.
34. Neumann J.R., Morency C.A., Russian K.O. A novel rapid assay for chloramphenicol acetyl transferase gene expression. BioTechniques. 5:1987;444-447.
35. Rouet P., Raguenez G., Salier J.P. Optimized assays for quantifying transient expressions of co-transfected β-galactosidase and CAT reporter genes. BioTechniques. 13:1992;700-701.
36. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
37. de The H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 343:1990;177-180.
38. Umesono K., Giguere V., Glass C.K., Rosenfeld M.G., Evans R.M. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature. 366:1988;262-265.
39. 3 receptors. Cell. 65:1991;1255-1266.
40. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science. 264:1994;1415-1421.
41. Vakalopoulou E., Schaack J., Shenk T. A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11:1991;3355-3364.
42. Marusich M.F., Furneaux H.M., Henion P.D., Weston J.A. Hu neuronal proteins are expressed in proliferating neurogenic cells. J. Neurobiol. 25:1994;143-155.
43. Chagnovich D., Cohn S.L. Binding of a 40-kd protein to the N-myc 3′-untranslated region correlates with enhanced N-myc expression in human neuroblastoma. J. Biol. Chem. 271:1996;33580-33586.
44. Corvi R., Savelyeva L., Schwab M. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res. 55:1995;3471-3474.
45. Oberg F., Larsson L.G., Anton R., Nilsson K. Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts. Proc. Natl. Acad. Sci. USA. 88:1991;5567-5571.
46. Lindeman G.J., Harris A.W., Bath M.L., Eisenman R.N., Adams J.M. Overexpressed max is not oncogenic and attenuates myc induced lymphoproliferation and lymphomagenesis in transgenic mice. Oncogene. 10:1995;1013-1017.
47. Peverali F.A., Orioli D., Tonon L., Ciana P., Bunone G., Negri M., Della-Valle G. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene. 12:1996;457-462.